April 16, 2015 News by Patricia Silva, PhD Experimental Drug Appears to Repair Nerve Damage in Multiple Sclerosis Patients The American Academy of Neurology (AAN)Ā recently announced the results of a new study that evaluated an experimental drug for multiple sclerosis (MS) with the potential to repair damaged myelin layers, a fatty material that covers and protects neurons. These findings will be presented at the 67th AAN Annual Meeting,…
April 13, 2015 News by admin Biogen to Focus on RRMS Disease Management, Treatment at Upcoming Conference Biogen plans toĀ present new clinical data at the 67th American Academy of Neurology (AAN) Annual Meeting in Washington D.C., April 18 ā 25, 2015, including numerous presentations focusing on multiple sclerosis. Ā In a company press release, Biogen statedĀ āAt AAN, we will feature new scientific data, including research highlighting the…
April 8, 2015 News by Isaura Santos Multiple Sclerosis Patients Could One Day Benefit From Brain Boost Study A recent study suggests that in the futureĀ multiple sclerosis patients could benefit from treatments intendedĀ to boost their brain function. The study was published inĀ Nature NeuroscienceĀ and receivedĀ funding fromĀ The Wellcome Trust, the Lister Research Prize and the Biotechnology and Biological Sciences Research Council. According to researchers, patients…
March 17, 2015 News by Patricia Silva, PhD Hypertension Medication Found to Offer Protective Effect Against Multiple Sclerosis Symptoms in Mice A new study recently published in the journal Nature CommunicationsĀ led by researchers at The University of ChicagoĀ revealed that a drug for hypertension has a protective effect against symptoms characteristic of multiple sclerosis (MS) in mouse models. The study is entitled āPharmaceutical integrated…
March 2, 2015 News by admin Multiple Sclerosis Treatments Benefit From Discovery of New Inflammatory Molecule A newly discovered molecule could play a pivotal role in inflammatory diseases, including multiple sclerosis, according to researchers at Trinity College Dublin and the University of Queensland Australia. The study was published in the journal Nature Medicine,Ā and describes aĀ molecule known as MCC950 that can suppress the ‘NLRP3 inflammasome’,…
December 12, 2014 News by admin Unraveling Myelin’s Mystery With Neutron Diffraction Researchers have uncovered new information about myelin, a fatty substance that wraps around the axons of brain cells (neurons) allowing them to transmit information quickly from one cell to another. De-myelinating diseases in which the insulating wrap is damaged include multiple sclerosis, in which unpredictable loss of myelin causes…
June 25, 2014 News by Patricia Silva, PhD Roche Turns to MS Research on Agreement with Versant Ventures The Swiss pharmaceutical companyĀ RocheĀ recently announced a partnership agreement with California-based Inception Sciences and venture capital firm Versant Ventures. The three companies will work together to form a new company, Inception 5, which will be dedicated mostly to the development of therapies for multiple sclerosis. Inception 5’s research will focus…